Tesaro, Inc. to Participate in Several Upcoming Investor Conferences

Published: Aug 30, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WALTHAM, Mass., Aug. 30, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, announced that Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President of TESARO, will participate in several upcoming investor conferences during the month of September, including:

Help employers find you! Check out all the jobs and post your resume.

Back to news